MENUNews Archive
Date: 04/10/2024
Highlights from Rogel's presence at the 2024 AACR Annual Meeting
Date: 04/10/2024
Abhijit Parolia, M.S., Ph.D., assistant professor of pathology and urology at the University of Michigan Health Rogel Cancer Center, was named at NextGen Star by the American Association of Cancer Research.
Date: 04/09/2024
Mats Ljungman, Ph.D., Rogel researcher and professor of radiation oncology, shared research on KLIPP, a new technique in precision medicine using CRISPR to target weak spots in cancer cells, at the American Association of Cancer Research's Annual Meeting.
Date: 04/07/2024
Arul Chinnaiyan, M.D., Ph.D., was one of several Rogel researchers to present at the American Association for Cancer Research 2024 Annual Meeting.
Date: 03/25/2024
Rogel Cancer Center faculty and trainees will lead nearly 70 presentations, posters and moderated sessions at the American Association for Cancer Research annual meeting.
Date: 03/13/2024
Calista Harbaugh, MS, MD., colon and rectal surgeon and health services researcher, is leading the charge to help reduce as many positive margin instances among Michigan colorectal cancer patients as possible. In 2023, Harbaugh’s “Leveraging the Michigan Surgical Quality Collaborative (MSQC) to Improve Statewide Colorectal Cancer” project was awarded a $50,000 Investigator Initiated Research grant from the Blue Cross Blue Shield of Michigan (BCBSM) Foundation.
Date: 03/06/2024
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center. This could assist many patients in a quicker return to their normal lives.
Date: 03/05/2024
Experts at University of Michigan Health Rogel Cancer Center have conducted the first study evaluating the effectiveness of a targeted drug for patients with salivary gland cancers (SGC).
Date: 02/28/2024
Researchers at the University of Michigan Health Rogel Cancer Center are exploiting a unique biological feature of glioblastoma to gain a better understanding of how this puzzling brain cancer develops and how to target new treatments against it. The team developed human and mouse models of glioblastoma oncostreams and examined multiple factors in the tumor microenvironment that could impact how oncostreams develop and how to reverse them.
Date: 02/06/2024
Programs and services aimed at helping people reduce their risk of cancer don’t always meet the needs of people from diverse communities and cultures.